Axogen (AXGN) Depreciation & Amortization (CF) (2011 - 2026)
Axogen (AXGN) posted quarterly Depreciation & Amortization (CF) of $1.6 million for Q2 2026, down 3.02% year-over-year from $1.7 million in Q2 2025, and little changed quarter-over-quarter from $1.6 million in Q1 2026.
Axogen (AXGN) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends
Axogen's Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $1.6 million for Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) fell 3.02% year-over-year to $1.6 million; the TTM figure through Jun 2026 stood at $6.5 million (down 2.83% YoY), while the FY2025 annual figure was $6.7 million, up 2.98% from the prior year.
- Depreciation & Amortization (CF) for Q2 2026 stood at $1.6 million, roughly flat from $1.6 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $1.7 million in Q1 2025, with the low at $645000.0 in Q4 2022.
- The 5-year median for Depreciation & Amortization (CF) is $1.6 million (2023), against an average of $1.3 million.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) slipped 8.81% in 2022, then jumped 141.55% in 2023.
- Axogen's Depreciation & Amortization (CF) stood at $645000.0 in 2022, then surged by 141.55% to $1.6 million in 2023, then grew by 5.01% to $1.6 million in 2024, then dropped by 0.18% to $1.6 million in 2025, then declined by 1.59% to $1.6 million in 2026.
- Business Quant data shows AXGN's Depreciation & Amortization (CF) at $1.6 million in Q2 2026, $1.6 million in Q1 2026, and $1.6 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Axogen | 2.69 Bn | 2.58 Bn | 50.67 Mn | 1.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.61 Mn |
| Jun 30, 2026 | 1.61 Mn |
| Mar 31, 2026 | 1.60 Mn |
| Mar 31, 2026 | 1.60 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Dec 31, 2024 | 1.64 Mn |
| Dec 31, 2024 | 1.64 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Jun 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | 1.52 Mn |
| Mar 31, 2024 | 1.52 Mn |